Pelthos Therapeutics, Inc. (PTHS)

22.19 -0.21 (-0.94%) USD  |  NYAM  |  Sep 25, 16:00
22.34 +0.14 (+0.65%) After-Hours: 19:59
More

Pelthos Therapeutics Cost of Goods Sold (% of Quarterly Revenues)

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for PTHS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Quarterly Revenues) Chart
Start Trial

Historical Cost of Goods Sold (% of Quarterly Revenues) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
December 31, 2025 --
September 30, 2025 --

Cost of Goods Sold Definition

Returns the Cost of Goods Sold (COGS) for the period and date(s) requested in local currency by default.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks
Start Trial
Travere Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. --